Загрузка...
Integrated Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease
INTRODUCTION: Neurogenic orthostatic hypotension (nOH) is associated with neurodegenerative conditions, may cause symptoms of end‐organ hypoperfusion, increases fall risk, and can negatively impact quality of life. Droxidopa is approved for the treatment of symptomatic nOH in adults. As the largest...
Сохранить в:
| Опубликовано в: : | Mov Disord Clin Pract |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley & Sons, Inc.
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6277368/ https://ncbi.nlm.nih.gov/pubmed/30637284 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mdc3.12695 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|